Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma

Background: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a key enzyme that catalyzes the hydroxylation of lysine, plays a crucial role in the progression of several solid tumors. However, its spatial expression profile and prognostic significance in oral squamous cell carcinoma (OSCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yawei, Wang, Shuai, Zhang, Xingwei, Wu, Zhuhao, Li, Zihui, Ding, Zhuang, Huang, Xiaofeng, Chen, Sheng, Jing, Yue, Zhang, Xiaoxin, Ding, Liang, Song, Yuxian, Sun, Guowen, Ni, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699216/
https://www.ncbi.nlm.nih.gov/pubmed/34944486
http://dx.doi.org/10.3390/biom11121842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699216/
https://www.ncbi.nlm.nih.gov/pubmed/34944486
http://dx.doi.org/10.3390/biom11121842

Ejemplares similares